Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit

Taming Diabetes: A Daily Challenge for Martin and His Family

Follow 8-year-old Martin and his family as they navigate daily life with type 1 diabetes, from meal adaptations to school activities, showing resilience and optimism.

Living with T1D for 25 Years: Philippe's Inspiring Journey

At the dawn of his fifties, Philippe has tamed the diabetes he has lived with for over 25 years, along with his initial fear of injections. For him, this disease represents "a turning point, not an end." He leads a life "like everyone else," multiplying passions and fully enjoying every moment.

Research Review Product Summary

Gla-300 in patients with type 2 diabetes mellitus: Sustained glycaemic control with lower risk of hypoglycaemia and observed lower weight gain  

Switching to Toujeo® (insulin glargine 300 units/mL) from other regimens

Insulin is one of the most effective glucose-lowering agents for type 2 diabetes and can be titrated to suit an individual patient’s requirements.

Toujeo®: Insulin-Naive start Guide

A clinical guide for healthcare professionals on switching patients to Toujeo® (insulin glargine 300 units/mL) from other insulin regimens.

Seznam PCSK9i center

V tomto článku se dozvíte, kde najít seznam všech PCSK9i center.

DUPIXENT® - WISSEN kompakt

Częstość występowania i czynniki ryzyka nawrotów zdarzeń sercowo-naczyniowych w populacji z ostrym zespołem wieńcowym podczas długiego okresu obserwacji

Meningococcal Vaccination Impact: Hajj Pilgrimage Case Studies and Global Benefits

Comprehensive analysis of meningococcal vaccine effectiveness during Hajj pilgrimages, featuring case studies from Singapore and Saudi Arabia. Highlights significant reduction in IMD cases post-vaccination and explores the broader benefits of meningococcal conjugate vaccines, including herd immunity and reduced global transmission.

Beyond Survival: Why Does IMD Rank as a High-Impact, Low-Incidence Threat Among Other Vaccine-Preventable Diseases?"

Comprehensive analysis of Invasive Meningococcal Disease (IMD) outcomes, featuring detailed mortality rates by serogroup and age group, with focus on the 20% survivor sequelae rate. Includes comparative analysis with other vaccine-preventable diseases (VPDs) and highlights the critical 24-hour window for treatment intervention.

Protecting Pilgrims: Meningococcal Disease Risk Factors During Mass Gatherings

Comprehensive analysis of meningococcal disease risk factors during mass religious gatherings, with focus on the Hajj pilgrimage. Details environmental challenges, demographic vulnerabilities, and transmission dynamics among pilgrims, local residents, and healthcare workers in Mecca, with emphasis on crowded conditions and N. meningitidis carriage rates.